NEW YORK AP – Medical device maker Biomet Inc. said Monday it has started talks with the U.S. Attorney’s Office aimed at resolving an inquiry into past consulting and professional service agreements with orthopedic surgeons using or considering the use of the company’s hip or knee implants.
In a regulatory filing, the company said any resolution could require monetary payments, cause the company to significantly change some of its existing business practices, and include the potential for additional governmental oversight. Biomet said it intends to continue to cooperate fully with the Department of Justice inquiry, but can’t assure it will reach a consensual resolution.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
